SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057713
Filing Date
2024-05-10
Accepted
2024-05-10 15:05:17
Documents
98
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q btmd-20240331.htm   iXBRL 10-Q 2248912
2 EX-10.1 btmd-ex10_1.htm EX-10.1 298811
3 EX-31.1 btmd-ex31_1.htm EX-31.1 15127
4 EX-31.2 btmd-ex31_2.htm EX-31.2 15697
5 EX-32.1 btmd-ex32_1.htm EX-32.1 8672
6 EX-32.2 btmd-ex32_2.htm EX-32.2 9144
7 GRAPHIC img170576005_0.jpg GRAPHIC 3908
  Complete submission text file 0000950170-24-057713.txt   10871019

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT btmd-20240331.xsd EX-101.SCH 1874456
102 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20240331_htm.xml XML 1727067
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40128 | Film No.: 24934368
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)